Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Asset Utilization Ratio (2017 - 2025)

Historic Asset Utilization Ratio for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to 1.07.

  • Puma Biotechnology's Asset Utilization Ratio fell 684.85% to 1.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.07, marking a year-over-year decrease of 684.85%. This contributed to the annual value of 1.04 for FY2024, which is 27.08% down from last year.
  • Puma Biotechnology's Asset Utilization Ratio amounted to 1.07 in Q3 2025, which was down 684.85% from 1.22 recorded in Q2 2025.
  • Over the past 5 years, Puma Biotechnology's Asset Utilization Ratio peaked at 1.27 during Q2 2023, and registered a low of 0.94 during Q1 2022.
  • Its 5-year average for Asset Utilization Ratio is 1.11, with a median of 1.09 in 2023.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first soared by 3079.83% in 2023, then plummeted by 1771.49% in 2024.
  • Over the past 5 years, Puma Biotechnology's Asset Utilization Ratio (Quarter) stood at 1.12 in 2021, then increased by 6.27% to 1.19 in 2022, then dropped by 8.63% to 1.09 in 2023, then decreased by 2.18% to 1.06 in 2024, then grew by 0.37% to 1.07 in 2025.
  • Its Asset Utilization Ratio stands at 1.07 for Q3 2025, versus 1.22 for Q2 2025 and 1.14 for Q1 2025.